Medical innovation is often hindered by the high costs of clinical trials and the complexity of navigating government regulations and reporting requirements. For many companies, this prevents life-saving advances from reaching the market. Now, there is a way to accelerate human clinical trials and reduce development expenses. This represents one of the positive aspects of globalization. Julio Martinez-Clark, CEO of Bioaccess, is here today.
Key Takeaways To Tune In For:
(04:40) - Challenges of US Clinical Trials
(08:33) - Why Startups Look Overseas
(19:00) - Real-World Success Stories
(23:01) - Panama’s Role in Innovation
(27:49) - Global Trial Accelerators Podcast
Resources talked about in this episode:
Website:
Podcast: Global Trial Accelerators
Social media handles: LinkedIn